These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 5334614)
1. Aromatic amino acids and modification of parkinsonism. Cotzias GC; Van Woert MH; Schiffer LM N Engl J Med; 1967 Feb; 276(7):374-9. PubMed ID: 5334614 [No Abstract] [Full Text] [Related]
2. Modification of Parkinsonism--chronic treatment with L-dopa. Cotzias GC; Papavasiliou PS; Gellene R N Engl J Med; 1969 Feb; 280(7):337-45. PubMed ID: 4178641 [No Abstract] [Full Text] [Related]
3. [Use of L-DOPA in the therapy of parkinsonism]. D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A; Tedeschi G Rass Int Clin Ter; 1971 Feb; 51(4):193-221. PubMed ID: 4930734 [No Abstract] [Full Text] [Related]
4. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders. Timberlake WH Neurology; 1970 Dec; 20(12):Suppl:31-5. PubMed ID: 4921586 [No Abstract] [Full Text] [Related]
5. Parkinsonism and DOPA. Cotzias GC; Papavasiliou PS; Gellene R; Aronson RB Trans Assoc Am Physicians; 1968; 81():171-83. PubMed ID: 4889342 [No Abstract] [Full Text] [Related]
6. Metabolism and clinical assessment of L-dopa in parkinsonism. Ericsson AD; McCann D; Sharpless N; Reveno W Neurology; 1970 Apr; 20(4):402. PubMed ID: 4935027 [No Abstract] [Full Text] [Related]
7. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease. Muenter MD Neurology; 1970 Dec; 20(12):6-13. PubMed ID: 4924343 [No Abstract] [Full Text] [Related]
8. [Evaluation of L-DOPA in Parkinsonism with special reference to the study by double-blind method]. Okajima T; Kubota A; Nakahara N; Takeda S; Shimomura K Naika; 1972; 29(2):335-43. PubMed ID: 4552443 [No Abstract] [Full Text] [Related]
9. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism. Yahr MD; Duvoisin RC; Hoehn MM; Schear MJ; Barrett RE Trans Am Neurol Assoc; 1968; 93():56-63. PubMed ID: 4885744 [No Abstract] [Full Text] [Related]
10. L-dopa and amantadine in the therapy of parkinsonism. Weeth JB; Shealy CN; Mercier DA Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055 [No Abstract] [Full Text] [Related]
11. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders. Timberlake WH Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342 [No Abstract] [Full Text] [Related]
12. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease. Muenter MD Neurology; 1970 Dec; 20(12):Suppl:6-13. PubMed ID: 4921587 [No Abstract] [Full Text] [Related]
17. Experimental treatment of parkinsonism with L-Dopa. Cotzias GC; Papavasiliou PS; Gellene R Neurology; 1968 Mar; 18(3):276-7. PubMed ID: 4869717 [No Abstract] [Full Text] [Related]
18. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method]. Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721 [No Abstract] [Full Text] [Related]
19. [L-dopa and parkinsonism. A preliminary report]. Pakkenberg H Ugeskr Laeger; 1969 May; 131(22):959-60. PubMed ID: 5793628 [No Abstract] [Full Text] [Related]